Join Hands to Make a Win-Win Situation -- Eisai China launches its first liver reserve function testing device in China market-Eisai China lnc.
The local navigation starts here.
  • Company News
The text starts here.

  Join Hands to Make a Win-Win Situation -- Eisai China launches its first liver reserve function testing device in China market


Grand Launching Campaign

June 20, 2018, Eisai China Region held a grand launching campaign for its RK-1000 Model A, a new generation of ICG Clearance Meter, in JW Marriott Hotel Shanghai. The staff from Merchants Department and partners in China region got together witnessing the company’s first clinical diagnosis device hitting the market. The device will be promoted together with Indocyanine Green for Injection, a product of Eisai (Liaoning) Pharmaceutical Co. Ltd. This is an attempt of Eisai China to expend its business to a new field, which will enrich its product line in the treatment of hepatic diseases such as hepatic carcinoma, hepatic injury, hepatic encephalopathy, and etc., greatly improve its market competitiveness and provide better solution of diagnosis and treatment for both doctors and patients in China.


Mr. Dali Wang and Mr. Ningbo Cai introduced the company and the product

Eisai China always gives first thought to patients and their families, and contributes to increasing the benefits provided to them.
Mr. Dali Wang, Director of Merchants Department, indicated in his speech, “As a multi-national company focusing on the R&D of pharmaceutical products, Eisai always gives first thought to patients and their families, and contributes to increasing the benefits provided to them; and as a Japanese pharmaceutical company in China, we always adhere to our company philosophy, “human health care (hhc)”. In December 2015, through the full acquisition of a local pharmaceutical enterprise, Eisai China established Eisai (Liaoning) to enter the generic pharmaceutical business to expand its existing business focused on new medicines, in a bid to adapt to Chinese market. By providing a stable supply of high quality generic pharmaceuticals with reasonable price, Eisai China is able to fulfill an even wider range of medical needs in China. This is the mission of Eisai, in accordance with the company’s hhc philosophy. The new business in medical devices bears the same philosophy and spirit. We look forward to working together with our partners to better serve medical practitioners and benefit more Chinese patients.


Grand Launching Campaign

Liver reserve function testing is the technical basis of precise liver resection of the hepatobiliary surgery.
Yangqing Huang, Head of Shanghai Public Health Clinical Center, introduced the importance of the liver reserve function testing to hepatobiliary surgeons. Huang indicated that the liver reserve function testing is the technical basis for the precise liver resection in the hepatobiliary surgery, and ICG clearance test, currently a widely used quantitative assay method of the liver reserve function, is regarded as the standard evaluation index in a large number of guiding documents in both China and overseas.
Preoperative ICG clearance test helps assess the safe range of liver resection and reduce the incidence rate of postoperative liver failure and death, while the postoperative ICG clearance test can predict the incidence rate of liver dysfunction and severe complications.

In the campaign, the sponsor introduced in detail the clinically applicable departments of liver reserve function testing and the clinical benefits it brings, explained the guide documents, marketing strategies and gave product demonstrations.

Liver reserve function testing is applicable to multiple departments including hepatobiliary surgery, liver transplantation, hepatology, intervention, and etc. In the hepatobiliary surgery department it can be used to assess the safe range of liver resection, to reduce the risks of postoperative liver failure and death, and to predict the incidence rate of postoperative liver dysfunction. In the liver transplant department it can be used to evaluate the quality of the donor liver and the success rate of the operation. In the hepatology department it is manly used in the early diagnosis of liver injury and prognosis evaluation of cirrhosis. In the interventional department it can be used to guide the interventional operation plan and to evaluate the prognosis of operation.


RK-1000 Model A, a new generation of ICG Clearance Meter

The new generation ICG clearance tester RK-1000 Model A is a professional liver reserve function testing device with exclusive dynamic calibration technology and continuous spectrophotometric method bringing a lot of advantages such as dynamic, real-time, accurate, convenient test and so on. This device will be sure to bring more benefits to the broad masses of patients and clinical practitioners.